- Raised funding round, Nov 2024
About
Grace gene therapy is a revolutionary gene therapy treatment approach and groundbreaking solution to Parkinson’s disease, first in class chemo genetic agent, without competitor in the market. The unique treatment selectively targets the diseased region by precise biological brain neuromodulator, unlike the mainstream treatment today, which is based on the dopaminergic system.
The bio-tech treatment helps fix the neural network problems caused by Parkinson’s disease. It does this by adjusting certain parts of the brain (the basal ganglia) using special chemical tools called DREADDs (Designer Receptors Exclusively Activated by Designer Drugs). Neuroscientists now use DREADDs-based tools a lot. These tools help them study the brain circuits and signals that control things like behaviour, perceptions, emotions, natural drives, and movement in different species, from flies to non-human primates.
Funding history · 1 round · — total
Q&A
- What is Grace Gene Therapy's primary focus?
- Grace Gene Therapy is developing a revolutionary gene therapy treatment solution for Parkinson's disease.
- What is the core technology behind Grace Gene Therapy's treatment for Parkinson's disease?
- Grace Gene Therapy's treatment utilizes DREADDs (Designer Receptors Exclusively Activated by Designer Drugs) to selectively target and adjust specific regions of the brain, such as the basal ganglia, to address neural network problems caused by Parkinson's disease.
- When was Grace Gene Therapy founded?
- Grace Gene Therapy was founded in November 2024.
- How many employees does Grace Gene Therapy currently have?
- Grace Gene Therapy has 1-10 employees.
- Who is the CEO and Co-founder of Grace Gene Therapy?
- Fadi Assaf is the Co-founder and CEO of Grace Gene Therapy.
- What is Grace Gene Therapy's current funding stage?
- Grace Gene Therapy is currently in the Pre-Seed funding stage.
- Which investor participated in Grace Gene Therapy's funding round in November 2024?
- NGT HealthCare II participated in Grace Gene Therapy's funding round in November 2024.
- What sector does Grace Gene Therapy operate in?
- Grace Gene Therapy operates in the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
Team · 1
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | gracegenetherapy.com |
|---|
Identifiers & details
| Founded | 2024-11 |
|---|---|
| Employees (exact) | 4 |
Radar intelligence
Web history (Wayback)
| Domain | gracegenetherapy.com |
|---|
Certificate / subdomain footprint
| Subdomains | 0 |
|---|